0001415889-11-001117.txt : 20111014 0001415889-11-001117.hdr.sgml : 20111014 20111014142251 ACCESSION NUMBER: 0001415889-11-001117 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111013 FILED AS OF DATE: 20111014 DATE AS OF CHANGE: 20111014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURKE KIMBERLY A CENTRAL INDEX KEY: 0001532658 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35218 FILM NUMBER: 111141567 MAIL ADDRESS: STREET 1: ECHO THERAPEUTICS, INC. STREET 2: 8 PENN CENTER, 1628 JFK BLVD., STE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Echo Therapeutics, Inc. CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-717-4100 MAIL ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020702 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 3 1 form3-10142011_111041.xml X0204 3 2011-10-13 0 0001031927 Echo Therapeutics, Inc. ECTE 0001532658 BURKE KIMBERLY A 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 false true false false General Counsel Common Stock 175000 D Nonqualified Stock Option (Right to Buy) 0.40 2017-10-23 Common Stock 35000 D Incentive Stock Option (Right to Buy) 0.40 2018-06-30 Common Stock 65000 D Incentive Stock Option (Right to Buy) 0.40 2019-01-08 Common Stock 45000 D The restricted shares shall vest upon the first to occur of (i) FDA approval of the Company's Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities. The shares underlying this option fully vested on October 23, 2009. The shares underlying this option fully vested on June 30, 2010. The shares underlying this option fully vested on January 8, 2011. /s/ Kimberly A. Burke 2011-10-14